Additional file 1: Figure S1. of 
                     Ex vivo 
                     18O-labeling mass spectrometry identifies a peripheral amyloid β clearance pathway

Portelius, Erik; Mattsson, Niklas; Pannee, Josef; Zetterberg, Henrik; Gisslén, Magnus; Vanderstichele, Hugo; Gkanatsiou, Eleni; Crespi, Gabriela; Parker, Michael; Miles, Luke; Gobom, Johan; Blennow, Kaj

doi:10.6084/m9.figshare.c.3696196_D1.v1

13024_2017_152_MOESM1_ESM.pptx (74.9 kB)

Additional file 1: Figure S1. of Ex vivo 18O-labeling mass spectrometry identifies a peripheral amyloid β clearance pathway

presentation

posted on 2017-02-20, 05:00 authored by Erik Portelius, Niklas Mattsson, Josef Pannee, Henrik Zetterberg, Magnus Gisslén, Hugo Vanderstichele, Eleni Gkanatsiou, Gabriela Crespi, Michael Parker, Luke Miles, Johan Gobom, Kaj Blennow

MALDI-TOF MS CSF Aβ peptide patterns of a patient (A) in the acute phase of BM and (B) after antibiotic treatment. (PPTX 74 kb)

Funding

Royal Swedish Academy of Sciences

History

Usage metrics

Keywords

Amyloid β Mass spectrometry Stable isotope labeling Cerebrospinal fluid Insulin-degrading enzyme

Licence

CC BY + CC0

Exports

RefWorks

BibTeX

Ref. manager

Endnote

DataCite

NLM

DC